Insights

Here’s what happened to the Wesfarmers (ASX:WES) share price in September

The retail giant did not have its best month of trading…
The post Here’s what happened to the Wesfarmers (ASX:WES) share price in September appeared first on The Motley Fool Australia. –

The Wesfarmers Ltd (ASX: WES) share price had… an interesting September. Not that that was anything different to what the broader S&P/ASX 200 Index (ASX: XJO) experienced over the month that was. The ASX 200 ended up losing roughly 2.6% of its value over September.

But how did Wesfarmers do? After all, Wesfarmers is one of the bluest ASX 200 blue chips on the markets and is a major constituent of the ASX 200 itself.

So the Wesfarmers share price started the month off at $59.95 a share. It ended September at the price of $55.75. That means Wesfarmers shares went backwards by exactly 7% over the month.

That’s a pretty large number for one month’s efforts. Especially if you consider it’s a loss almost 3 times greater than the ASX 200’s. So what happened here?

September rains on ASX 200 parade

Well, it’s worth pointing out that Wesfarmers went ex-dividend for its upcoming final dividend payment on 1 September. Wesfarmers will be shelling out a final dividned of 90 cents per share, fully franked, on 8 October. When the company traded ex-dividend on 1 September, it gave the Wesfarmers share price more than just a pinch and a punch.

As we covered at the time, this initially sent Wesfarmers shares down as much as 3%. This is quite normal for a share trading ex-dividend with the value of the dividend leaving the share price as new investors aren’t entitled to the payout. Even so, it still contributed to Wesfarmers’ poor performance over the month.

Another factor that could have turned investors off Wesfarmers is the long-running battle to takeover Australian Pharmaceutical Industries Ltd (ASX: API). API is the company behind the Priceline chain of pharmacy stores.

Wesfarmers has lobbed more than one bid for API. Its most recent offer came in mid-September when the company offered up $1.55 for every API share on the market. It’s previous offer was valued at $1.38.

However, we learned last month that Sigma Healthcare Ltd (ASX: SIG) had also thrown its hat into the ring, putting up an offer worth $1.57 a share. As it stands today, there is no sign who will end up winning the bidding war. Although Wesfarmers has yet to top the offer Sigma has on the table. Perhaps this dampened investor enthusiasm for Wesfarmers shares in the back half of September.

About the Wesfarmers share price

Although September was a tough month for Wesfarmers, the picture looks more pleasing if we zoom out a little. The company is still up 6.25% year to date in 2021 so far and is also up by close to 22% over the past year.

At yesterday’s closing Wesfarmers share price, the company has a market capitalisation of $62.11 billion, a price-to-earnings (P/E) ratio of 26.06 and a dividend yield of 3.25%.

The post Here’s what happened to the Wesfarmers (ASX:WES) share price in September appeared first on The Motley Fool Australia.

Should you invest $1,000 in Wesfarmers right now?

Before you consider Wesfarmers, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Wesfarmers wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

5 defensive ASX shares to guide you through the market correction

5 things to watch on the ASX 200 on Wednesday

The RBA gives ASX 200 shares a slither of good news on a down day

These 3 ASX 200 shares are topping the volume charts this Tuesday

How has the AMP (ASX:AMP) share price beaten the market over the past week?

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!